EFMH
RDY icon

E Fund Management (HK)’s Dr. Reddy's Laboratories RDY Stock Holding History

E Fund Management (HK)’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.4K Buy
1,341
+340
+34% +$4.59K 0.01% 323
2026
Q1 		$13.9K Buy
+1,001
New +$13.9K 0.01% 280

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

E Fund Management (HK)'s RDY Position: Q2 2026 in Review

E Fund Management (HK) increased its Dr. Reddy's Laboratories (RDY) stake by 34% in Q2 2026, buying an estimated $4.59K and bringing the position to 1,341 shares worth $19.4K. The position accounts for 0.01% of the portfolio, ranked #323.

E Fund Management (HK) first reported a position in RDY in Q1 2026 and has held it in 2 quarters since. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • E Fund Management (HK) held 1,341 shares of Dr. Reddy's Laboratories worth $19.4K as of Q2 2026.
  • E Fund Management (HK) bought 340 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $4.59K.
  • Dr. Reddy's Laboratories made up 0.01% of E Fund Management (HK)'s portfolio in Q2 2026, its #323 holding.
  • E Fund Management (HK) first reported a position in Dr. Reddy's Laboratories in Q1 2026 and has held it in 2 quarters since.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.